FDA
-
-
-
-
-
-
-
Diality names Peter Donato as chief financial officer
-
-
-
-
-
-
-
Myriad Genetics Reports Third Quarter 2024 Financial Results; Updates 2024 Financial Guidance
-
-
-
-
-
-
-
Myriad Genetics Showcases New Research and Product Innovations Advancing Cancer Care at 2024 ASCO® Annual Meeting
-
-
-
-
-
-
-
Myriad Genetics (MYGN) and SimonMed Imaging Collaborate to Advance Precision Medicine
-
-
-
-
-
-
-
Myriad Genetics Showcases Advancements in Precision Medicine with Recent Oncology Portfolio Expansion and New Data Presentations at ASCO 2022
-
-
-
-
-
-
-
Myriad Genetics (MYGN) Announces New Precise Solution for Precision Oncology
-
-
-
-
-
-
-
New Analysis Published in Peer-reviewed Psychiatry Research Shows Advantages of Combinatorial Algorithm of GeneSight® Psychotropic Test
-
323,573 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

